n.a. (HNT)

pos +0.00
Today's Range: 0.00 - 0.00 | HNT Avg Daily Volume: 0
Last Update: 12/31/69 - 7:00 PM EST
Volume: 0
YTD Performance: 0.00%
Open: $0.00
Previous Close: $0.00
52 Week Range: $0.00 - $0.00
Oustanding Shares: 0
Market Cap: 0
6-Month Chart
TheStreet Ratings Grade for HNT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell
Mean Rec. 0.00 0.00 0.00 0.00
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 0.00
Price Earnings Comparisons:
HNT Sector Avg. S&P 500
0.00 0.00 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.00% 0.00% 0.00%
Revenue 0.00 0.00 0.00
Net Income 0.00 0.00 0.00
EPS 0.00 0.00 0.00
Earnings for HNT:
Revenue 0.00B
Average Earnings Estimates

Earnings Estimates data is not available for HNT.

Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

bearishHealth Net downgraded at Jefferies

Jul 15, 2015 | 7:17 AM EDT

HNT was downgraded to Hold from Buy, Jefferies said. Downgrading HNT to Hold following its acquisition by CNC, as the stock is nears Jefferies' $75 price target.


David Peltier

 | Jul 2, 2015 | 4:59 PM EDT

An uninspiring jobs report and uncertainty in Greece weighed on stocks before the holiday.

bullishHealth Net numbers upped at Leerink

Feb 11, 2015 | 7:33 AM EST

HNT estimates were boosted through 2016, Leerink Partners said. Management boosted guidance and will continue to repurchase shares. Market Perform rating and new $60 price target.


Jill Malandrino

 | Nov 5, 2014 | 1:34 PM EST
Cognizant Technology Solutions came in with solid Q3 earnings and provided favorable guidance for Q4 and FY14.

Doug Kass

 | Nov 3, 2014 | 7:22 AM EST
Where it began.

bearishHealth Net downgraded at Citi

Oct 24, 2014 | 7:39 AM EDT

HNT was downgraded from Buy to Sell, Citigroup said. Valuation call, as the stock is up 60% year-to-date.

bullishHealth Net numbers increased at Sterne Agee

Aug 8, 2014 | 7:48 AM EDT

HNT estimates were raised through 2015, Sterne Agee said. Company is realizing operating leverage. Buy rating and new $68 price target. 

bullishHealth Net price target raised at Deutsche

Aug 7, 2014 | 7:53 AM EDT

HNT target was increased to $42, Deutsche Bank said. Hold rating. Company announced G&A outsourcing deal with Cognizant. 


Doug Kass

 | Aug 6, 2014 | 7:57 AM EDT
Where it began.

bullishHealth Net upgraded at BofA/Merrill

Jul 24, 2014 | 7:33 AM EDT

HNT was upgraded from Underperform to Buy, Bank of America/Merrill Lynch said. Margins on new growth will likely be better than expected. $59 price target. 

volatility is quite low here, and we could see some downsides here in the short...
this chart is showing great bullish...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.